Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids.
暂无分享,去创建一个
[1] C. Cutler,et al. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. , 1999, Journal of periodontology.
[2] F. Numano,et al. The Effect of Glucose and Advanced Glycosylation End Products on IL‐6 Production by Human Monocytes , 1994, Annals of the New York Academy of Sciences.
[3] J. Slots,et al. Casual or Causal Relationship between Periodontal Infection and Non-oral Disease? , 1998, Journal of dental research.
[4] N. Savage,et al. Characterization of serum antibodies to Porphyromonas gingivalis in individuals with and without periodontitis. , 1998, Oral microbiology and immunology.
[5] J. Ainamo,et al. Periodontal conditions in insulin-dependent diabetes mellitus. , 1992, Journal of clinical periodontology.
[6] A. Iacopino,et al. Diabetic periodontitis: possible lipid-induced defect in tissue repair through alteration of macrophage phenotype and function. , 2008, Oral diseases.
[7] J. Mcghee,et al. Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammation. , 1997, Journal of periodontal research.
[8] S. Socransky,et al. Levels of interleukin 1 beta in tissue from sites of active periodontal disease. , 1991, Journal of clinical periodontology.
[9] R. Genco,et al. A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells , 1997, Infection and immunity.
[10] D. Williamson,et al. Dental disease and risk of coronary heart disease and mortality. , 1993, BMJ.
[11] F. Pociot,et al. A Tumour Necrosis Factor Beta Gene Polymorphism in Relation to Monokine Secretion and Insulin‐Dependent Diabetes Mellitus , 1991, Scandinavian journal of immunology.
[12] R. G. Deshpande,et al. Invasion of Aortic and Heart Endothelial Cells byPorphyromonas gingivalis , 1998, Infection and Immunity.
[13] R. Elkeles,et al. Treatment of diabetes: the effect on serum lipids and lipoproteins. , 1991, Postgraduate medical journal.
[14] C. Cutler,et al. Functional differences in human neutrophils isolated pre‐ and post‐prandially , 1991, FEBS letters.
[15] J. Nilsson,et al. Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDL , 1996 .
[16] R. Genco,et al. Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). , 1982, Journal of the American Dental Association.
[17] Y. Kono,et al. Cytokines and periodontal disease: immunopathological role of interleukins for B cell responses in chronic inflamed gingival tissues. , 1993, Journal of periodontology.
[18] A. Tabares,et al. Triglyceride kinetics, tissue lipoprotein lipase, and liver lipogenesis in septic rats. , 1990, The American journal of physiology.
[19] G. Seymour,et al. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. , 1997, Periodontology 2000.
[20] R. Bone,et al. Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.
[21] R. Jonsson,et al. Some microbiological, histopathological and immunohistochemical characteristics of progressive periodontal disease. , 1994, Journal of clinical periodontology.
[22] R. Jackson,et al. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. , 1994, Journal of lipid research.
[23] S. Takashiba,et al. Periodontal disease as a complication of diabetes mellitus. , 1998, Annals of periodontology.
[24] G. Koch,et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. , 1994, Journal of periodontology.
[25] G. Chrousos,et al. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.
[26] T. Tervonen,et al. Relation of diabetes control to periodontal pocketing and alveolar bone level. , 1986, Oral surgery, oral medicine, and oral pathology.
[27] A. Dutta-Roy,et al. Insulin mediated processes in platelets, erythrocytes and monocytes/macrophages: effects of essential fatty acid metabolism. , 1994, Prostaglandins, leukotrienes, and essential fatty acids.
[28] A. Cambon-Thomsen,et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF‐a and TNF‐0 by human mononuclear cells: a possible link to insulin‐dependent diabetes mellitus , 1993 .
[29] S. Offenbacher. Periodontal diseases: pathogenesis. , 1996, Annals of periodontology.
[30] J. Selby,et al. Epidemiology and Prevention of Periodontal Disease in Individuals With Diabetes , 1991, Diabetes Care.
[31] R. Tilvis,et al. Fatty acid compositions of serum lipids, erythrocytes, and platelets in insulin-dependent diabetic women. , 1985, The Journal of clinical endocrinology and metabolism.
[32] M. Boermeester,et al. Effect of hypertriglyceridemia on endotoxin responsiveness in humans , 1995, Infection and immunity.
[33] A. Garg. Lipid-Lowering Therapy and Macrovascular Disease in Diabetes Mellitus , 1992, Diabetes.
[34] R. Arnold,et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. , 1997, Journal of periodontology.
[35] H. Imura,et al. Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems , 1991, Clinical endocrinology.
[36] A. Cerami,et al. Detection of circulating tumor necrosis factor after endotoxin administration. , 1988, The New England journal of medicine.
[37] Lopes-Virella Mf. Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. , 1993 .
[38] B. Michalowicz,et al. Detection of local and systemic cytokines in adult periodontitis. , 1996, Journal of periodontology.
[39] A. D. Smith,et al. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. , 1984, Biochimica et biophysica acta.
[40] H. Kiyono,et al. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis , 1998 .
[41] S. Offenbacher,et al. Changes in crevicular fluid levels of interleukin‐1β, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor α in experimental gingivitis in humans , 1993 .
[42] H. Löe. Periodontal Disease: The sixth complication of diabetes mellitus , 1993, Diabetes Care.
[43] H. Birkedal‐Hansen. Role of cytokines and inflammatory mediators in tissue destruction. , 1993, Journal of periodontal research.
[44] G. Lowe. Etiopathogenesis of cardiovascular disease: hemostasis, thrombosis, and vascular medicine. , 1998, Annals of periodontology.
[45] G. Chisolm,et al. Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation. , 1987, The Journal of biological chemistry.
[46] T. Hagve,et al. Effects of unsaturated fatty acids on cell membrane functions. , 1988, Scandinavian journal of clinical and laboratory investigation.
[47] W. Loesche,et al. Interactions between periodontal disease, medical diseases and immunity in the older individual. , 1998, Periodontology 2000.
[48] W. Beisel,et al. Hypertriglyceridemia produced by endotoxin: role of impaired triglyceride disposal mechanisms. , 1976, The Journal of infectious diseases.
[49] P. Conneally,et al. Periodontal disease in diabetics. , 1967, Journal of periodontology.
[50] S. Socransky,et al. The Bacterial Etiology of Destructive Periodontal Disease: Current Concepts. , 1992, Journal of periodontology.
[51] T. Collins. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[52] C. Cutler,et al. Diabetes prevents periodontitis-induced increases in gingival platelet derived growth factor-B and interleukin 1-beta in a rat model. , 1998, Journal of periodontology.
[53] R. Page,et al. The role of inflammatory mediators in the pathogenesis of periodontal disease. , 1991, Journal of periodontal research.
[54] S. Amar,et al. Lipopolysaccharide-inducible and salicylate-sensitive nuclear factor(s) on human tumor necrosis factor alpha promoter , 1995, Infection and immunity.
[55] S. Offenbacher,et al. Diabetes as a modifier of periodontal disease expression. , 1994, Periodontology 2000.
[56] R. Page. The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. , 1998, Annals of periodontology.
[57] C. Cutler,et al. Association between periodontitis and hyperlipidemia: cause or effect? , 1999, Journal of periodontology.
[58] T. Ervasti,et al. Relation between control of diabetes and gingival bleeding. , 1985, Journal of periodontology.
[59] M. Garg,et al. Dietary fat: exogenous determination of membrane structure and cell function , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] R. Tompkins. Human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome. , 1994, Critical care medicine.
[61] J. Ainamo,et al. A site-by-site follow-up study on the effect of controlled versus poorly controlled insulin-dependent diabetes mellitus. , 1994, Journal of clinical periodontology.
[62] J. Beck,et al. Periodontal Infection as a Possible Risk Factor for Preterm Low Birth Weight. , 1996, Journal of periodontology.
[63] J. Mølvig. A model of the pathogenesis of insulin-dependent diabetes mellitus. , 1992, Danish medical bulletin.
[64] N. Schneiderman,et al. Insulin, health behaviors, and lipid metabolism. , 1993, Metabolism: clinical and experimental.
[65] S. Clarke,et al. Regulation of gene transcription by polyunsaturated fatty acids. , 1993, Progress in lipid research.
[66] S. Socransky,et al. Potential pathogenic mechanisms of periodontitis associated pregnancy complications. , 1998, Annals of periodontology.
[67] B. Howard,et al. Lipoprotein metabolism in diabetes mellitus. , 1987, Journal of lipid research.
[68] K N Frayn,et al. Sepsis and fat metabolism , 1996, The British journal of surgery.
[69] A. Schmidt,et al. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. , 1993, The Journal of clinical investigation.
[70] R. Genco,et al. Periodontal disease and diabetes mellitus: a two-way relationship. , 1998, Annals of periodontology.
[71] R. Genco. Periodontal disease and risk for myocardial infarction and cardiovascular disease , 1998 .
[72] K. Feingold,et al. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. , 1987, The Journal of clinical investigation.
[73] S. Fried,et al. Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. , 1989, Journal of lipid research.
[74] J. Gallin,et al. Serum lipids in infection. , 1969, The New England journal of medicine.
[75] O. Arisaka,et al. Fatty acid and prostaglandin metabolism in children with diabetes mellitus. II. The effect of evening primrose oil supplementation on serum fatty acid and plasma prostaglandin levels. , 1991, Prostaglandins, leukotrienes, and essential fatty acids.
[76] C. Cutler,et al. Diabetes-induced impairment of macrophage cytokine release in a rat model: potential role of serum lipids. , 1998, Life sciences.
[77] T. Poll,et al. Tumour necrosis factor-α: Its role in the metabolic response to sepsis , 1993 .
[78] Horrobin Df. The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus. , 1988 .
[79] J. Hayashi,et al. Effects of cytokines and periodontopathic bacteria on the leukocyte function-associated antigen 1/intercellular adhesion molecule 1 pathway in gingival fibroblasts in adult periodontitis , 1994, Infection and immunity.
[80] F. Scannapieco. Position paper of The American Academy of Periodontology: periodontal disease as a potential risk factor for systemic diseases. , 1998, Journal of periodontology.
[81] I. Lamster,et al. Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis: implications for periodontal diagnosis. , 1998, Journal of clinical periodontology.
[82] S. M. Sims,et al. Osteoclast activation in inflammatory periodontal diseases. , 2008, Oral diseases.
[83] C. Dinarello,et al. The role of interleukin-1 in disease. , 1993, The New England journal of medicine.
[84] S. Offenbacher,et al. Diagnostic Potential of Host Response Mediators , 1993, Advances in dental research.
[85] S. Nares,et al. In vitro alteration of macrophage phenotype and function by serum lipids , 1999, Cell and Tissue Research.
[86] K. O. Elliston,et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.
[87] A. Iacopino,et al. Platelet-derived growth factor levels in wounds of diabetic rats. , 1995, Life sciences.
[88] B. Howard. Lipoprotein metabolism in diabetes. , 1994, Current opinion in lipidology.
[89] T. van der Poll,et al. Model for whole body production of tumour necrosis factor-alpha in experimental endotoxaemia in healthy subjects. , 1994, Clinical science.
[90] A. Dasanayake. Poor periodontal health of the pregnant woman as a risk factor for low birth weight. , 1998, Annals of periodontology.
[91] R. Arnold,et al. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. , 1997, Journal of clinical periodontology.
[92] S. Socransky,et al. Serum antibodies reacting with subgingival species in refractory periodontitis subjects. , 1998, Journal of clinical periodontology.
[93] K. Hove,et al. Diabetes and the periodontal patient. , 1970, Journal of periodontology.
[94] C. Alvarez,et al. Lipids, lipoproteins, and apoproteins in serum during infection. , 1986, Clinical chemistry.
[95] K. Feingold,et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. , 1992, Journal of lipid research.
[96] A. Gwosdow,et al. Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis. , 1990, The American journal of physiology.
[97] J. Beck,et al. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. , 1998, Annals of periodontology.
[98] P. Eke,et al. Defective neutrophil function in an insulin-dependent diabetes mellitus patients. A case report. , 1991, Journal of periodontology.
[99] A. Schmidt,et al. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[100] M. Barnett,et al. Absence of periodontitis in a population of insulin-dependent diabetes mellitus (IDDM) patients. , 1984, Journal of periodontology.
[101] P. Fives-Taylor,et al. Models of invasion of enteric and periodontal pathogens into epithelial cells: a comparative analysis. , 1997, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[102] R. Genco,et al. Periodontal disease in non-insulin-dependent diabetes mellitus. , 1991, Journal of periodontology.
[103] K. Manogue,et al. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. , 1988, Science.
[104] M. Nieminen,et al. Association between dental health and acute myocardial infarction. , 1989, BMJ.
[105] M. Meyer,et al. Dental plaque, platelets, and cardiovascular diseases. , 1998, Annals of periodontology.
[106] M. Jensen,et al. Stimulation of Lipolysis in Humans by Physiological Hypercortisolemia , 1991, Diabetes.
[107] T. Sayers,et al. Relationship of TNF to interleukins. , 1992, Immunology series.
[108] M. Kaste,et al. Dental infections in association with cerebral infarction in young and middle‐aged men , 1989, Journal of internal medicine.